Acute Cough Assessment and Evidence‑Based Management
Red‑Flag Evaluation
- Hemoptysis in an adult with cough warrants immediate referral for bronchoscopy to exclude serious airway pathology. 1
- New‑onset breathlessness accompanying cough should prompt assessment for asthma, anaphylaxis, or pneumonia. [1][2]
- Fever with purulent sputum signals possible serious bacterial lung infection and requires urgent investigation. 1
- A history of foreign‑body inhalation mandates specialist referral for airway evaluation. 1
- Voice change may indicate vocal‑cord palsy and should be investigated. 1
- Physical findings such as dullness on percussion, bronchial breath sounds, and crackles suggest pneumonia and guide further imaging. [1][3]
Diagnostic Considerations
Acute Viral Upper Respiratory Infection (most likely)
- Typical presentation includes rhinitis, pharyngitis, mild fever and malaise; cough duration of 10 days remains within the acute‑cough window (< 3 weeks). [1][4]
- Chest radiography is usually normal in uncomplicated viral URIs. 3
Post‑Infectious Cough (if symptoms persist > 3 weeks)
- Defined as cough lasting 3–8 weeks after an acute respiratory infection. [5][6]7
Pertussis (whooping cough)
- Consider when cough ≥ 2 weeks is associated with paroxysmal coughing, post‑tussive vomiting, or an inspiratory “whoop.” Definitive diagnosis is by nasopharyngeal aspirate or swab culture. [5][6][7][8]
Medication‑Induced Cough
- A trial discontinuation of atorvastatin for 1–2 weeks can help determine if a dry cough is drug‑related; symptom resolution supports the diagnosis. 4
Non‑Pharmacologic Symptomatic Care
- Honey and lemon mixture is an inexpensive, evidence‑supported first‑line remedy for acute cough. [1][3]9
- Voluntary cough suppression (e.g., breathing techniques) may reduce cough frequency via central modulation. [1][3]
Pharmacologic Cough Suppression
First‑Line Antitussives
Dextromethorphan 60 mg (maximum recommended dose) provides effective cough reflex suppression; lower OTC doses are sub‑therapeutic. [1][3]2
- Caution: Verify combination products for hidden acetaminophen to avoid overdose. [1][3]
Menthol inhalation offers short‑lasting but measurable cough relief. [1][3]2
First‑generation sedating antihistamines can be used for nocturnal cough, acknowledging drowsiness as a side effect. [1][3]2
Agents to Avoid
Opioid antitussives (codeine, pholcodine) have significant adverse effects without superior efficacy and should not be used. [1][3]2
Antibiotics have no role in acute viral cough and contribute to antimicrobial resistance. [1][5][6][7]
Management of Sub‑Acute/Post‑Infectious Cough (≥ 3 weeks)
| Step | Recommendation | Evidence Grade |
|---|---|---|
| 1 | Inhaled ipratropium bromide as first‑line therapy. | B |
| 2 | If ipratropium fails and quality of life is impaired, add inhaled corticosteroid (e.g., budesonide 0.5 mg BID). | B |
| 3 | For severe paroxysmal cough after excluding UACS, asthma, and GERD, a short course of oral prednisone 30–40 mg daily may be considered. | B |
| 4 | Central antitussives (codeine or dextromethorphan) as last‑resort when other measures are ineffective. | B |
- All steps are supported by the Chest guideline series. [5][6][7][8]
Indications for Chest Radiography
- Persistent cough > 3 weeks, presence of red‑flag symptoms (hemoptysis, breathlessness, prolonged fever), or comorbidities such as diabetes, heart disease, asthma, or COPD warrant a chest X‑ray. [1][9]10
Common Pitfalls (to avoid)
- Prescribing antibiotics for acute viral cough provides no benefit and promotes resistance. [1][5][6][7]
- Using sub‑therapeutic doses of dextromethorphan; the effective dose is 60 mg. [1][3]2
- Skipping ipratropium and proceeding directly to inhaled corticosteroids in sub‑acute cough. (Guideline recommends ipratropium first.)
- Failing to test for pertussis when paroxysmal cough features develop. [5][7]8
Follow‑Up and Monitoring
- Re‑evaluate cough at 3 weeks; if it persists, initiate the sub‑acute cough protocol. [5][4]
- Employ a validated cough severity instrument (e.g., Leicester Cough Questionnaire) to objectively track treatment response. 4
Management of Persistent Post‑URI Cough: Evidence‑Based Recommendations
Definition and Diagnosis
- Post‑infectious cough is defined as a cough that persists 3–8 weeks after an acute respiratory infection, and this time frame should guide therapeutic decisions. 11
Required Exclusions Before Initiating Corticosteroids
- Prior to any corticosteroid therapy, clinicians must exclude common alternative causes such as upper‑airway cough syndrome (e.g., rhinosinus disease), gastro‑esophageal reflux disease, and pertussis infection, especially when paroxysmal features are present. 11
First‑Line Pharmacologic Therapy
- The American College of Chest Physicians (ACCP) guidelines recommend inhaled ipratropium bromide as the initial treatment for post‑infectious cough (Grade B evidence). 11
Second‑Line Pharmacologic Therapy (Inhaled Corticosteroids)
- Inhaled corticosteroids (e.g., budesonide 0.5 mg twice daily) should be considered only if:
Oral Prednisone Use and Tapering
- ACCP advises a short course of oral prednisone (30–40 mg daily) only for severe paroxysms of post‑infectious cough after other causes have been ruled out. 11
- A prednisone taper is not recommended for this indication. 11
Antibiotic Therapy
- Antibiotics have no role in the management of post‑infectious cough because the underlying cause is not bacterial. 11
Common Clinical Pitfalls to Avoid
- Skipping ipratropium and proceeding directly to inhaled corticosteroids is discouraged. 11
- Failing to test for pertussis when paroxysmal cough features are present should be avoided. 11
- Neglecting systematic exclusion of upper‑airway cough syndrome, asthma, and GERD when the cough does not respond to initial therapy is a frequent error. 11